학술논문

Omalizumab for the treatment of chronic spontaneous urticaria in daily clinical practice in South Spain.
Document Type
Article
Source
Dermatologic Therapy. Sep2018, Vol. 31 Issue 5, pN.PAG-N.PAG. 1p.
Subject
*URTICARIA
*ANTI-immunoglobulin E autoantibodies
*TREATMENT effectiveness
*RANDOMIZED controlled trials
Language
ISSN
1396-0296
Abstract
The article talks about chronic urticaria, a common and often debilitating dermatological condition defined by the sudden appearance of wheals, angioedema or both. It is noted that omalizumab, an anti-IgE therapy has proven effective in treating chronic spontaneous urticaria in South Spain. The article adds that double-blind, randomized, placebo-controlled studies with omalizumab-treated versus placebo-treated patients with CSU and omalizumab was found to effective in CSU management.